Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects

Diabetic retinopathy (DR) is the main cause of vision loss or blindness in working age adults worldwide. The lack of effective diagnostic biomarkers for DR leads to unsatisfactory curative treatments. To define potential metabolite biomarkers for DR diagnosis, a multiplatform‐based metabolomics stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Xuan, Qiuhui, Ouyang, Yang, Wang, Yanfeng, Wu, Liang, Li, Huating, Luo, Yuanyuan, Zhao, Xinjie, Feng, Disheng, Qin, Wangshu, Hu, Chunxiu, Zhou, Lina, Liu, Xinyu, Zou, Haidong, Cai, Chun, Wu, Jiarui, Jia, Weiping, Xu, Guowang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675050/
https://www.ncbi.nlm.nih.gov/pubmed/33240754
http://dx.doi.org/10.1002/advs.202001714

Ejemplares similares

Ejemplares similares